CompletedEarly Phase 1NCT00460928
Preventive IVIG Therapy for Congenital Heart Block
Studying Congenital heart block
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Jill P. Buyon, MDNYU Langone Health
- Intervention
- intravenous immune globulin (IVIG)(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-50 years · FEMALE
- Timeline
- 2007 – 2009
Study locations (2)
- Saint Barnabas Medical Center, Livingston, New Jersey, United States
- New York University School of Medicine / NYU-Hospital for Joint Diseases, New York, New York, United States
Collaborators
Lupus Research Alliance
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00460928 on ClinicalTrials.govOther trials for Congenital heart block
Additional recruiting or active studies for the same condition.